Media Coverage · August 1, 2018
Le français Acticor Biotech signe un accord de développement en Chine – La Tribune [FR]
August 2018. La société française Acticor Biotech a annoncé mardi la signature avec le groupe pharmaceutique chinois China Medical System (CMS) …
Download full text article (PDF, French)
Read next in 'Media Coverage'
- ACT017 : un fragment d’anticorps dont l’ACTion antithrombotique est prometteuse !
- Novel antiplatelet could circumvent bleeding risk for stroke patients
- Experimental antiplatelet compound for acute stroke shows promise
- New drug to prevent clots clears safety hurdle
- New blood thinner may prevent stroke, without risk for bleeding